Inovio Halts Head And Neck Cancer Trial On Safety Concerns
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm prematurely stopped a pivotal oncology study investigating its tumor ablation technology after an independent data monitoring committee raised concerns about adverse events.
You may also be interested in...
Inovio, VGX Plan Merger For Vaccines
Electroporation-focused Inovio finds an “amazing” fit, CEO says.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.